🇺🇸 KRYS — Krystal Biotech, Inc.

Salud Compra fuerte
← Volver

Precio actual

305,03 USD

Máx. histórico

378,15

127 días

Caída desde máximo

-19,34%

Rango 52 semanas

192,52 – 382,54

Variación hoy

+3,09%

Cierre anterior

295,90

Rango de hoy

293,26 – 305,43

Volumen hoy

603.048

Peor caída histórica

-53,42%

01/03/2021 → 26/11/2021

Recuperado en 3 días

Volatilidad anualizada ⓘ

73,07%

Información
Nombre completo
Krystal Biotech, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
295
PER ⓘ
41,44 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
393,56 USD (puede no estar actualizado)
Primera cotización
20/09/2017
Precio actualizado
hace 18 horas
Sobre la empresa

Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States. The company commercializes VYJUVEK (beremagene geperpavec-svdt, or B-VEC) for the treatment of dystrophic epidermolysis bullosa (DEB). It also develops KB803 for ocular complications of dystrophic epidermolysis bullosa; KB801 for neurotrophic keratitis; KB407, which is in Phase 1 clinical trials for treating cystic fibrosis; KB111 for Hailey-Hailey disease; KB707 for solid tumors; KB304 for dynamic wrinkles; KB707 that is in Phase 1/2 clinical trials for the treatment of anti-PD-1 relapsed/refractory; KB408, which is in Phase 1 clinical trials for treating Alpha-1 antitrypsin deficiency; and KB301 that is in Phase 2 clinical trials for treating aesthetic skin conditions, as well as in open label study with ophthalmic B-VEC for treating for ocular complications of deb. Krystal Biotech, Inc. was founded in 2016 and is headquartered in Pittsburgh, Pennsylvania.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
15/03/2019 19,87 21,84 19,87 21,10 +6,24% 9,91% 115.700
14/03/2019 19,78 20,06 18,50 19,86 +0,00% 7,89% 142.700
13/03/2019 21,40 21,40 19,60 19,86 -5,65% 8,41% 121.100
12/03/2019 20,71 22,00 18,87 21,05 +1,64% 15,14% 123.200
11/03/2019 22,27 22,79 19,99 20,71 -6,59% 12,57% 185.100
08/03/2019 23,28 23,34 21,60 22,17 -4,81% 7,49% 71.000
07/03/2019 23,98 24,20 23,01 23,29 -1,94% 4,96% 71.600
06/03/2019 22,78 24,00 21,90 23,75 +5,09% 9,22% 103.600
05/03/2019 21,90 22,70 21,90 22,60 +2,73% 3,65% 57.800
04/03/2019 22,83 23,10 21,80 22,00 -3,30% 5,67% 75.400
01/03/2019 22,99 22,99 21,70 22,75 +1,74% 5,61% 42.900
28/02/2019 23,27 23,70 22,09 22,36 -4,03% 6,92% 43.400
27/02/2019 22,93 23,65 22,73 23,30 +1,95% 4,01% 64.500
26/02/2019 22,66 23,63 22,24 22,86 +0,91% 6,13% 69.100
25/02/2019 22,75 23,12 21,97 22,65 +0,35% 5,08% 85.800
22/02/2019 22,41 23,11 21,90 22,57 +1,07% 5,41% 61.000
21/02/2019 22,99 22,99 22,22 22,33 -1,33% 3,35% 23.600
20/02/2019 22,79 23,00 22,44 22,63 -0,75% 2,46% 26.100
19/02/2019 22,95 23,00 22,36 22,80 -0,83% 2,79% 26.900
15/02/2019 22,31 23,45 21,90 22,99 +3,23% 6,95% 36.400
14/02/2019 22,31 22,45 21,51 22,27 -0,58% 4,23% 65.400
13/02/2019 22,22 23,21 21,08 22,40 +1,08% 9,59% 54.600
12/02/2019 22,43 22,96 22,10 22,16 -0,49% 3,83% 55.100
11/02/2019 23,11 23,51 22,16 22,27 -3,72% 5,84% 19.400
08/02/2019 22,73 24,44 21,33 23,13 +1,89% 13,68% 36.400
07/02/2019 23,33 24,37 22,19 22,70 -3,40% 9,34% 20.500
06/02/2019 23,30 23,62 23,06 23,50 +0,90% 2,40% 24.900
05/02/2019 23,63 24,47 23,17 23,29 -0,72% 5,51% 16.100
04/02/2019 23,52 24,04 23,46 23,46 -0,13% 2,47% 31.600
01/02/2019 23,25 24,35 23,25 23,49 +1,60% 4,73% 57.200